Mauna Kea Technologies
Medical device company developing a real-time in vivo cellular imaging system.
MKEA | PA
Overview
Corporate Details
- ISIN(s):
- FR0010609263 (+4 more)
- LEI:
- 5493007KMDG4MFIGJJ63
- Country:
- France
- Address:
- 9 RUE D'ENGHIEN, 75010 PARIS
- Website:
- https://www.maunakeatech.com/en/
- Sector:
- Manufacturing
Description
Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2015-03-17 17:45 |
Mauna Kea Technologies receives additional CPT® reimbursement code in the U.S s…
|
English | 440.5 KB | ||
| 2015-03-11 20:47 |
MAUNA KEA TECHNOLOGIES annonce l’accélération des installations et de l'utilisa…
|
French | 466.6 KB | ||
| 2015-03-11 20:47 |
MAUNA KEA TECHNOLOGIES announces acceleration of installations and use of Cellv…
|
English | 430.2 KB | ||
| 2015-03-04 18:00 |
Information mensuelle relative au nombre total de droits de vote et d’actions c…
|
French | 116.1 KB | ||
| 2015-03-03 18:03 |
MAUNA KEA TECHNOLGIES, DEUX NOUVELLES PUBLICATIONS PAR UNE ÉQUIPE CHINOISE DE R…
|
French | 438.5 KB | ||
| 2015-03-03 18:03 |
MAUNA KEA TECHNOLGIES, TWO NEW PUBLICATIONS FROM LEADING TEAM IN CHINA PRESENT …
|
English | 352.4 KB | ||
| 2015-02-09 18:00 |
Information mensuelle relative au nombre total de droits de vote et d’actions c…
|
French | 118.6 KB | ||
| 2015-01-27 17:45 |
MAUNA KEA TECHNOLOGIES : RÉSULTATS POSITIFS DE L’ESSAI CLINIQUE PIVOT FOCUS SUR…
|
French | 596.9 KB | ||
| 2015-01-27 17:45 |
MAUNA KEA TECHNOLOGIES ANNOUNCES POSITIVE RESULTS FROM FOCUS PIVOTAL CLINICAL T…
|
English | 399.6 KB | ||
| 2015-01-20 17:45 |
MAUNA KEA TECHNOLOGIES ANNONCE LA PUBLICATION D’UN RAPPORT DE CONSENSUS CLINIQU…
|
French | 602.7 KB | ||
| 2015-01-14 18:00 |
MAUNA KEA TECHNOLOGIES : LA REVUE ENDOSCOPY PUBLIE UN ÉDITORIAL PRÉSENTANT LES …
|
French | 547.8 KB | ||
| 2015-01-14 18:00 |
MAUNA KEA TECHNOLOGIES: EDITORIAL HIGHLIGHTING ADVANTAGES OF NEEDLE-BASED ENDOM…
|
English | 425.2 KB | ||
| 2015-01-07 18:00 |
MAUNA KEA TECHNOLOGIES ANNOUNCES 2014 SALES GROWTH OF +10% TO €11.0M
|
English | 464.2 KB | ||
| 2015-01-07 18:00 |
MAUNA KEA TECHNOLOGIES, CHIFFRE D’AFFAIRES 2014 : CROISSANCE DE +10% À 11,0 M€
|
French | 534.1 KB | ||
| 2015-01-06 18:00 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GI…
|
French | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all Mauna Kea Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mauna Kea Technologies
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mauna Kea Technologies via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||